Savara Inc reports results for the quarter ended in June - Earnings Summary
13/08/2024 02:19
* Savara Inc SVRA.OQ reported a quarterly adjusted loss
of 12
cents per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of -7
cents. The mean expectation of six analysts for the quarter was
for a loss of 11 cents per share. Wall Street expected
results to range from -12 cents to -10 cents per share.
* Reported revenue was zero; analysts expected zero.
* Savara Inc's reported EPS for the quarter was a loss of 12
cents.
* The company reported a quarterly loss of $22.24 million.
* Savara Inc shares had fallen by 1.2% this quarter and
lost 15.3%
so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Savara Inc is
$10.00
This summary was machine generated from LSEG data August 13 at
01:18 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.11 -0.12 Missed
Mar. 31 2024 -0.10 -0.11 Missed
Dec. 31 2023 -0.10 -0.09 Beat
Sep. 30 2023 -0.07 -0.10 Missed